Zeng, H., Lv, H., Zhang, M., Niu, L., Wang, J., Sun, H., . . . Yan, M. Docetaxel rechallenge in HER2-negative metastatic breast cancer: A real-world study of previously discontinued patients for non-progression reasons. Springer.
Chicago Style (17th ed.) CitationZeng, Hui-Ai, Hui-Min Lv, Meng-Wei Zhang, Li-Min Niu, Jing Wang, Hui-Hui Sun, Zhen-Zhen Liu, and Min Yan. Docetaxel Rechallenge in HER2-negative Metastatic Breast Cancer: A Real-world Study of Previously Discontinued Patients for Non-progression Reasons. Springer.
MLA (9th ed.) CitationZeng, Hui-Ai, et al. Docetaxel Rechallenge in HER2-negative Metastatic Breast Cancer: A Real-world Study of Previously Discontinued Patients for Non-progression Reasons. Springer.
Warning: These citations may not always be 100% accurate.